Search

Displaying results 4931 - 4940 of 10000 in total
  1. Drug

    Murocainide

    go.drugbank.com/drugs/DB21243
    Experimental

    Murocainide has a monoisotopic molecular weight of 377.2 Da. … Murocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Murocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  2. Drug

    Zocainone

    go.drugbank.com/drugs/DB21326
    Experimental

    Zocainone has a monoisotopic molecular weight of 353.2 Da. … Zocainone is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Zocainone is a class I antiarrhythmic, procainamide and lidocaine derivative.

  3. Drug

    Atrimustine

    go.drugbank.com/drugs/DB21376
    Experimental

    Atrimustine has a monoisotopic molecular weight of 719.28 Da. … Atrimustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Atrimustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  4. Drug

    Pirenperone

    go.drugbank.com/drugs/DB21405
    Experimental

    Pirenperone has a monoisotopic molecular weight of 393.19 Da. … Pirenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Pirenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  5. Drug

    Cinsebrutinib

    go.drugbank.com/drugs/DB21640
    Experimental

    Cinsebrutinib has a monoisotopic molecular weight of 383.2 Da. … Cinsebrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  6. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax has a monoisotopic molecular weight of 1038.41 Da. … Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  7. Drug

    Pexidartinib

    go.drugbank.com/drugs/DB12978
    ApprovedInvestigational

    [A182240,L7901] Debilitating symptoms often follow with tenosynovial giant cell tumors, along with a risk of significant functional limitations and a reduced quality of life in patients. … [L7901] While surgical resection is a current standard of care for tenosynovial giant cell tumor, there are tumor types where surgeries are deemed clinically ineffective with a high risk of lifetime

    Categories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  8. Drug

    Meprobamate

    go.drugbank.com/drugs/DB00371
    ApprovedIllicit

    A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. … (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Meprobamate is a controlled substance in the U.S.

  9. Drug

    Abarelix

    go.drugbank.com/drugs/DB00106
    ApprovedWithdrawn

    It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.

  10. Drug

    Betazole

    go.drugbank.com/drugs/DB00272
    Approved

    A histamine H2 agonist used clinically to test gastric secretory function.